LAG3 and glioma: In contrast, Harris-Bookman et al. observed that 66% of glioblastoma samples in a small cohort of 9 cases displayed variable LAG-3 expression on perivascular lymphocytes while no WHO grade II-III glioma or IDH-mt cases were analyzed [13].